Abstract
Inducible nitric oxide synthase (iNOS) is induced by inflammatory cytokines in skeletal muscle and fat. It has been proposed that chronic iNOS induction may cause muscle insulin resistance. Here we show that iNOS expression is increased in muscle and fat of genetic and dietary models of obesity. Moreover, mice in which the gene encoding iNOS was disrupted (Nos2−/− mice) are protected from high-fat–induced insulin resistance. Whereas both wild-type and Nos2−/− mice developed obesity on the high-fat diet, obese Nos2−/− mice exhibited improved glucose tolerance, normal insulin sensitivity in vivo and normal insulin-stimulated glucose uptake in muscles. iNOS induction in obese wild-type mice was associated with impairments in phosphatidylinositol 3-kinase and Akt activation by insulin in muscle. These defects were fully prevented in obese Nos2−/− mice. These findings provide genetic evidence that iNOS is involved in the development of muscle insulin resistance in diet-induced obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Moncada, S. & Higgs, A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002–2012 (1993).
Nathan, C. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100, 2417–23 (1997).
Dawson, V.L. & Dawson, T.M. Physiological and toxicological actions of nitric oxide in the central nervous system. Adv. Pharmacol. 34, 323–342 (1995).
Parkinson, J.F., Mitrovic, B. & Merrill, J.E. The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75, 174–86 (1997).
Stichtenoth, D.O. & Frolich, J.C. Nitric oxide and inflammatory joint diseases. Br. J. Rheumatol. 37, 246–257 (1998).
Behr-Roussel, D. et al. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-l-lysine or with l-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 102, 1033–1038 (2000).
Cromheeke, K.M. et al. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc. Res. 43, 744–754 (1999).
Shimabukuro, M., Ohneda, M., Lee, Y. & Unger, R.H. Role of nitric oxide in obesity-induced β cell disease. J. Clin. Invest. 100, 290–295 (1997).
Shimabukuro, M., Zhou, Y.T., Levi, M. & Unger, R.H. Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 95, 2498–2502 (1998).
Zhou, Y.T. et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. USA 97, 1784–9 (2000).
Ginsberg, H.N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 106, 453–458 (2000).
Grundy, S.M. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83, 25F–29F (1999).
Shulman, G.I. Cellular mechanisms of insulin resistance in humans. Am. J. Cardiol. 84, 3J–10J (1999).
Pickup, J.C. & Crook, M.A. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41, 1241–1248 (1998).
Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. & Spiegelman, B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95, 2409–2415 (1995).
Yudkin, J.S., Stehouwer, C.D., Emeis, J.J. & Coppack, S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19, 972–978 (1999).
Hotamisligil, G.S., Shargill, N.S. & Spiegelman, B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993).
Hotamisligil, G.S. & Spiegelman, B.M. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43, 1271–1278 (1994).
Hotamisligil, G.S., Murray, D.L., Choy, L.N. & Spiegelman, B.M. Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91, 4854–4858 (1994).
Hotamisligil, G.S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF–α- and obesity-induced insulin resistance. Science 271, 665–668 (1996).
Stephens, J.M., Lee, J. & Pilch, P.F. Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272, 971–976 (1997).
Bedard, S., Marcotte, B. & Marette, A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem. J. 325, 487–493 (1997).
Kapur, S., Bedard, S., Marcotte, B., Cote, C.H. & Marette, A. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46, 1691–1700 (1997).
Kapur, S., Marcotte, B. & Marette, A. Mechanism of adipose tissue iNOS induction in endotoxemia. Am. J. Physiol. 276, E635–641 (1999).
Zierath, J.R., Houseknecht, K.L., Gnudi, L. & Kahn, B.B. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46, 215–223 (1997).
Wang, Q. et al. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell Biol. 19, 4008–4018 (1999).
Anai, M. et al. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat–fed rats. Diabetes 48, 158–169 (1999).
Pilon, G., Penfornis, P. & Marette, A. Nitric oxide production by adipocytes: a role in the pathogenesis of insulin resistance? Horm. Metab. Res. 32, 480–484 (2000).
Liu, D. et al. Cytokines induce apoptosis in β-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS−/−). Diabetes 49, 1116–1122 (2000).
Despres, J.P. et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334, 952–957 (1996).
Weyer, C., Hanson, R.L., Tataranni, P.A., Bogardus, C. & Pratley, R.E. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49, 2094–2101 (2000).
Garvey, E.P. et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272, 4959–4963 (1997).
McMillan, K. et al. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc. Natl. Acad. Sci. USA 97, 1506–1511 (2000).
Saltiel, A.R. & Olefsky, J.M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45, 1661–1669 (1996).
Kwon, G., Xu, G., Marshall, C.A. & McDaniel, M.L. Tumor necrosis factor α-induced pancreatic β-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Δ,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor γ activation and inos expression. J. Biol. Chem. 274, 18702–18708 (1999).
Li, M., Pascual, G. & Glass, C.K. Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol. 20, 4699–4707 (2000).
Maggi, L.B. Jr et al. Anti-inflammatory actions of 15-deoxy-Δ 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49, 346–355 (2000).
MacMicking, J.D. et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide. Cell 81, 641–50 (1995); erratum: 81, 1170 (1995).
Laubach, V.E., Shesely, E.G., Smithies, O. & Sherman, P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92, 10688–10692 (1995).
Tremblay, F., Lavigne, C., Jacques, H. & Marette, A. Defective insulin-induced glut4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both akt/protein kinase b and atypical protein kinase c (ζ/λ) activities. Diabetes 50, 1901–1910 (2001).
Tesauro, M. et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl. Acad. Sci. USA 97, 2832–2835 (2000).
Perreault, M., Dombrowski, L. & Marette, A. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats. Diabetologia 43, 427–437 (2000).
Acknowledgements
We thank B. Marcotte and J. Lalonde for technical assistance; F. Tremblay for help with the determination of PI 3-kinase activity; R. Labrecque for help with the maintenance and care of the transgenic mice lines; C. Nathan for advice; and Y. Deshaies and C.H. Côté for critical reading of the manuscript. This work was supported by grants from the Canadian Institutes for Health Research (to A.M.).
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Perreault, M., Marette, A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7, 1138–1143 (2001). https://doi.org/10.1038/nm1001-1138
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1001-1138
This article is cited by
-
β-sitosterol attenuates high- fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway
BMC Pharmacology and Toxicology (2023)
-
Perivascular macrophages in high-fat diet-induced hypothalamic inflammation
Journal of Neuroinflammation (2022)
-
The manifold roles of protein S-nitrosylation in the life of insulin
Nature Reviews Endocrinology (2022)
-
Metabolically healthy obesity and metabolically obese normal weight: a review
Journal of Physiology and Biochemistry (2021)
-
Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration
Nature Cancer (2021)